NL-OMON40284已完成不适用
Advanced Glycation End products in Children with Obesity and Children with Diabetes Mellitus type 1 - GLYCOD
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 99（—）
入选标准
- •-<24 years of age
- •-Diabetes Mellitus Type 1 OR Obesity
排除标准
- •-A dark-colored skin with a reflectance below 12%, measured with the AGE Reader.
- •-Use of sun protection cream up to 5 days or self tanner up to 14 days before examination.
研究者
相似试验
尚未招募
不适用
Advanced Glycation End Products in Patients with Peripheral Arterial Occlusive Disease or Abdominal Aortic AneurysmPatients with an abdominal aortic aneurysm (AAA) or peripheral arterial occlusive disease (PAOD) with and without diabetes mellitus.NL-OMON29072niversity Medical Center Groningen120
已完成
不适用
Advanced glycation end products in patients with peripheral artery disease or abdominal aortic aneurysmsPeripheral artery disease - atherosclerosis of the leg1000318410003216NL-OMON45188niversitair Medisch Centrum Groningen180
已完成
不适用
Are the levels of Advanced Glycation Endproducts (AGE*s) associated with Paratonia in Alzheimer*s Disease (AD)?Paratonia/ Movement stiffness100184241002803710012272NL-OMON38761Hanzehogeschool Groningen144
已完成
不适用
Advanced Glycation Endproducts (AGEs) in pregnancies complicated by diabetes mellitus and the accumulation of AGEs in the neonatesdiabetesDysglycemia1001265310010273NL-OMON34029niversitair Medisch Centrum Groningen550
已完成
不适用
Accumulation of advanced glycation endproducts in patients with systemic amyloidosis.EiwitvouwziekteProtein folding diseaseAmyloidosisNL-OMON42888Reumatologie en Klinische Immunologie100